Abstract

Although many health professionals believe that exercise protects the athletes against thrombosis, it is discussed whether elite athletes are exposed to many thrombogenic acquired risk factors such as: dehydration, hemoconcentration, repeated microtraumas and extended periods of immobilization during travel or injury. Additionally, the use of combined oral contraceptive (COC) may increases the risk of venous thrombosis fourfold in healthy women. We report a case of a 21-years-old professional female football athlete who developed deep vein thrombosis (DVT) followed by pulmonary embolism (PE). The outpatient hypercoagulability workup was negative and the case was associated to the use of COC pills. The patient was treated with rivaroxaban for 5 months, with complete resolution of the symptoms. There are a few cases in the literature of venous thromboembolism (VTE) involving athletes. Cases of VTE attributable to the use of COC are extremely rare in this population. The diagnosis of VTE in athletes is a challenge for physicians, because the symptoms may erroneously be confused with musculoskeletal complaints. Team physicians who work with female athletes should be alert to modifiable risk factors for VTE, as well as able to perform the early diagnosis and initial clinical management of this condition. DVT should be considered as a differential diagnosis of calf pain in women, especially in athletes, due to the well-defined increase on the risk of thrombosis with the use of COC pills.

Highlights

  • The venous thromboembolism (VTE) comprises deep vein thrombosis (DVT) and pulmonary embolism (PE) [1]

  • We report a case of DVT followed by PE in a professional female football player

  • The diagnosis of VTE in athletes is a challenge for physicians, especially because the symptoms may erroneously be confused with musculoskeletal complaints

Read more

Summary

Introduction

The venous thromboembolism (VTE) comprises deep vein thrombosis (DVT) and pulmonary embolism (PE) [1]. The incidence for the first episode of VTE is approximately 1.4 per 1000 persons/year, in accordance to a Norwegian population-based study. The real incidence of DVT is unknown. This is attributable to the occurrence of thrombosis with spontaneous resolution and cases of undefined diagnosis [3]. Acute PE is the most severe clinical presentation of the VTE and, in most cases, is a consequence of DVT [4]. The incidence of PE, associated or not with DVT, was 34.2 per 100,000 person-years in a prospective cohort study. DVT should be considered as a possible diagnosis in young healthy athletes with symptoms of lower extremity pain or swelling [3]

Case Report
Findings
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call